ArticleJournal of translational medicine2015

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas.

Antonella Manca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.